On March 6, 2019 Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, reported it will present at the following upcoming investor conferences (Press release, Syros Pharmaceuticals, MAR 6, 2019, View Source [SID1234534033]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen and Company 39th Annual Health Care Conference in Boston on Wednesday, March 13, 2019 at 10:00 a.m. ET.
Oppenheimer 29th Annual Healthcare Conference in New York City on Wednesday March 20, 2019 at 3:20 p.m. ET.
The company will also participate in the 31st Annual ROTH Conference in Laguna Niguel, Calif., on Monday, March 18, 2019.

Live webcasts of the presentations will be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of the webcasts will be available for approximately 30 days following each presentation.